1Yoda murakami M, Taniguchi M, Takahashi K, et al. Change in expression of CBP28P adiponectin in carbon tetrachloride - administrated mouse liver[ J]. Biochem Biophys Res Commun, 2001,285 (2): 372 - 377.
2Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to Clq, produced exclusively in adipocytes[ J]. Biol Chem, 1995, 270(45 ) : 26746 - 26749.
3Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose - specific gene dysregulated in obesity[J]. Biol Chem, 1996, 271 (18) : 10697 - 10703.
4Maeda K, Okubo K, Shimomura I, et al. eDNA cloning and expression of a novel adipose specific collagen - like factor, apM1 ( Adipose most abundant gene transcript 1 ) [ J]. Biochem Biophys Res Commun, 1996, 221(2):286-289.
5Wang Y, Xu A, Knight C, et al. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin: potential role in the modulation of its insulin - sensitizing activity [ J ]. Biol Chem, 2002, 277 ( 22 ) : 19521 - 19529.
6Yamauchi T, Kamon J. Cloning of adiponectin receptors that mediate antidiabetie metabolic effects[ J]. Nature, 2003, 423:762 - 769.
8Philip M, Myssa C, Ashley N, et al. p38 Mitogen - activated Protein Kinase Activates Peroxisome Proliferator- activarted Receptor a[J]. Biol Chem, 2001, 276:44495-44501.
9You M, Matsumoto M. The role of AMP - activated protein kinase in the action of ethanol in the liver[ J]. Gastroenterology, 2004,127: 1798 - 1808.
10Xu A, Wang Y, Hussila K, et al. The fat -derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J]. Clin Invest, 2003, 112:91 - 100.
2Hotta K, Funahashi T, Arita Y, et al. Plasma concentration of a novel,adipose-specific protein, adiponectin, in type 2 diabetic patients.Arterioscler Thromb Vasc Biol, 2000,20 : 1595-1599.
4Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes. A candidate gene for the insulin resistance syndrome. Diabetes, 2002,51:2325-2328.
5Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999,257:79-83.
6Hotta K, Funahashi T, Bodkin N, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in Rhesus monkeys. Diabetes, 2001,1126-1133.
7Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001,86 : 1930-1935.
8Pratley RE, Weyer C, Bogards C, et al. Metabolic abnormalities in the development of noninsulin-dependent diabetes mellitus. In : LeRoith D,et al (eds). Diabetes mellitus, 2nd ed. Philadelphia: Lippincot-Raven Publish, 2000,548-557.
9Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin, Int J Obse, 2000,24:861-868.
10Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits NF-KB signaling through a cAMP-dependent pathway. Circulation, 2000,102 : 1296-1301.
